홈/주식/SXTPW

SXTPW

60 Degrees Pharmaceuticals Inc. Warrant

$0.052+0.000 (0.000%)

실시간 가격

가격 차트

Loading Chart...

핵심 지표

시장 지표

기업 기본 정보

거래 통계

시장 지표

시가

$0.000

고가

$0.000

저가

$0.000

거래량

0.00M

기업 기본 정보

거래 통계

관련 뉴스

2025년 6월 3일 · 오후 12:49

GlobeNewswire

Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals

25,000 U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000A full 45 percent of persistent babesiosis cases include chronic fatigueHealthcare providers treating

Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals

2025년 5월 15일 · 오후 08:31

GlobeNewswire

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results

Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand.Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP;